Nipocalimab Dose Selection for A Phase 3 Study in Adult Patients with Generalized Myasthenia Gravis

Presentation information

General Poster Presentation

Fri. May 31, 2024 5:30 PM - 7:00 PM Poster (Bldg.1 1F Event Hall)

^○Sho Matsuyama, Sayuri Watanabe (Janssen Pharmaceutical K.K., Tokyo, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.